Apple

President Biden failed to overturn a U.S. International Trade Commission ban on sales and imports of Watch Series 9 and Watch Ultra 2.

The biotechnology company told MobiHealthNews it will continue to work within the digital health space through partnerships linked to its 'evolving R&D and commercial priorities.'

The Apple Watch Series 9 allows users to log and access healthcare data, and to control the Watch by double-tapping their index finger and thumb.

The company will first use the patent to combine the Apple Watch with Apple's new augmented reality headset Apple Vision Pro for closed loop AI-enabled treatment.

The Apple watchOS 10 will allow users to track their emotions and moods, connect with mental health resources and measure time spent outdoors to reduce the risk of myopia.

The jury was unable to reach a verdict in the case related to the Apple Watch's health monitoring capabilities.

Consumers can earn rewards points, grocery coupons and discounts for closing their activity rings on their Apple Watch or iPhone.

The U.S. International Trade Commission determined Apple Watches with ECG functionality violate AliveCor patents, but an import ban is on hold until appeals wrap up in a case before the U.S. Patent and Trademark Office's Patent Trial and Appeal Board.

The company will use the investment to scale its platform and expand its proprietary database.

The Patent Trial and Appeal Board determined three AliveCor patents regarding the detection of heart conditions like cardiac arrhythmias were unpatentable.